Using the dataset (Agesen et al. 2012) (GSE24551) to determine the if the expression of DLG2 resulted in altered survivability in colorectal cancer patients we performed a Kaplan–Meier survival analysis, with high DLG2 expression increasing the probability of 5-year patient survival. This evidence concerns the gene DLG2 and colorectal cancer.